Heterogeneity of sensitization profiles and clinical phenotypes among patients with seasonal allergic rhinitis in Southern European countries—The @IT.2020 multicenter study
Allergy · 2024-04 · 79 (4) · 908-923
DOI: 10.1111/all.16029 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Allergy, online erschienen am 05.02.2024. Verfasst von S Dramburg und 55 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Respiratory Care, Immunology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Rhinitis, Allergic, Seasonal, Hypersensitivity. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Euroimmun.
Abstract (Originalsprache)
Background
Pollen allergy poses a significant health and economic burden in Europe. Disease patterns are relatively homogeneous within Central and Northern European countries. However, no study broadly assessed the features of seasonal allergic rhinitis (SAR) across different Southern European countries with a standardized approach.
Objective
To describe sensitization profiles and clinical phenotypes of pollen allergic patients in nine Southern European cities with a uniform methodological approach.
Methods
Within the @IT.2020 multicenter observational study, pediatric and adult patients suffering from SAR were recruited in nine urban study centers located in seven countries. Clinical questionnaires, skin prick tests (SPT) and specific IgE (sIgE) tests with a customized multiplex assay (Euroimmun Labordiagnostika, Lübeck, Germany) were performed.
Results
Three hundred forty‐eight children (mean age 13.1 years, SD: 2.4 years) and 467 adults (mean age 35.7 years SD: 10.0 years) with a predominantly moderate to severe, persistent phenotype of SAR were recruited. Grass pollen major allergenic molecules (Phl p 1 and/or Phl p 5) ranged among the top three sensitizers in all study centers. Sensitization profiles were very heterogeneous, considering that patients in Rome were highly poly‐sensitized (sIgE to 3.8 major allergenic molecules per patient), while mono‐sensitization was prominent and heterogeneous in other cities, such as Marseille (sIgE to Cup a 1: n = 55/80, 68.8%) and Messina (sIgE to Par j 2: n = 47/82, 57.3%). Co‐sensitization to perennial allergens, as well as allergic comorbidities also broadly varied between study centers.
Conclusions
In Southern European countries, pollen allergy is heterogeneous in terms of sensitization profiles and clinical manifestations. Despite the complexity, a unique molecular, multiplex, and customized in‐vitro IgE test detected relevant sensitization in all study centers. Nevertheless, this geographical diversity in pollen allergic patients imposes localized clinical guidelines and study protocols for clinical trials of SAR in this climatically complex region.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Respiratory Care, Immunology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Department of Biology, Tor Vergata University, Rome, Italy.
- Italian Aerobiology Monitoring Network - Italian Aerobiology Association, Rome, Italy.
- Pediatric Allergy Unit, Sandro Pertini Hospital, Rome, Italy.
- Allergolology Service, Policlinico Casilino, Rome, Italy.
ORCID-Profile: S Dramburg, O Goksel, A Mazon, N G Papadopoulos, A M Pereira, C Sackesen, P Xepapadaki, P M Matricardi
Förderung
- Euroimmun
Zitieren
APA
Dramburg, S., Grittner, U., Potapova, E., Travaglini, A., Tripodi, S., Arasi, S., Pelosi, S., Acar Şahin, A., Aggelidis, X., Barbalace, A., Bourgoin, A., Bregu, B., Brighetti, M. A., Caeiro, E., Caglayan Sozmen, S., Caminiti, L., Charpin, D., Couto, M., Delgado, L., …, & Matricardi, P. M. (2024). Heterogeneity of sensitization profiles and clinical phenotypes among patients with seasonal allergic rhinitis in Southern European countries—The @IT.2020 multicenter study. Allergy, 79(4), 908-923. https://doi.org/10.1111/all.16029
Vancouver
Dramburg S, Grittner U, Potapova E, Travaglini A, Tripodi S, Arasi S, et al. Heterogeneity of sensitization profiles and clinical phenotypes among patients with seasonal allergic rhinitis in Southern European countries—The @IT.2020 multicenter study. Allergy. 2024;79(4):908-923. doi:10.1111/all.16029
BibTeX
@article{Dramburg2024,
author = {Dramburg, S and Grittner, U and Potapova, E and Travaglini, A and Tripodi, S and Arasi, S and Pelosi, S and Acar Şahin, A and Aggelidis, X and Barbalace, A and Bourgoin, A and Bregu, B and Brighetti, M A and Caeiro, E and Caglayan Sozmen, S and Caminiti, L and Charpin, D and Couto, M and Delgado, L and Di Rienzo Businco, A and Dimier, C and Dimou, M V and Fonseca, J A and Goksel, O and Hernandez, D and Hernandez Toro, C J and Hoffmann, T M and Jang, D T and Kalpaklioglu, F and Lame, B and Llusar, R and Makris, M and Mazon, A and Mesonjesi, E and Nieto, A and Öztürk, A B and Pahus, L and Pajno, G and Panasiti, I and Papadopoulos, N G and Pellegrini, E and Pereira, A M and Pereira, M and Pinar, N M and Priftanji, A and Psarros, F and Sackesen, C and Sfika, I and Suarez, J and Thibaudon, M and Uguz, U and Verdier, V and Villella, V and Xepapadaki, P and Yazici, D and Matricardi, P M},
title = {Heterogeneity of sensitization profiles and clinical phenotypes among patients with seasonal allergic rhinitis in Southern European countries—The @IT.2020 multicenter study},
journal = {Allergy},
year = {2024},
volume = {79},
number = {4},
pages = {908--923},
doi = {10.1111/all.16029}
}
EUVIMED